CRISPR technologies continue to open new doors in gene editing research. The CRISPR-Cas9 system, in particular, has become one of the most powerful tools in modern biotechnology due to its ability to perform precise cuts on DNA for genetic modification. However, the increasing widespread use of these technologies has also sparked a significant safety debate. Genetically modified microorganisms are no longer used only in laboratory settings; they are employed in many different fields, from biofuels to pharmaceuticals. The uncontrolled spread of these microorganisms into the environment or their continued proliferation outside the laboratory is considered one of the biggest concerns in biosafety. This is why researchers have been intensely working on biological “kill switches”, or termination mechanisms, that can safely deactivate these organisms when necessary.
Can Significantly Enhance the Safety of Genetically Modified Microorganisms
One of the most notable studies in this area came this week from Seoul National University. Researchers at the university developed a next-generation CRISPR biocontainment system that can permanently disable genetically modified bacteria without physically cutting their DNA. According to the researchers, this system could significantly increase the safety of genetically modified microorganisms used particularly in industrial biotechnology and biopharmaceutical fields.
Existing CRISPR-Cas9 systems typically work by cutting the double-helix structure of DNA. While this method inactivates target genes, it can lead to genome instability, unwanted mutations, and cellular stress responses. The new approach developed by the Seoul National University team overcomes this problem with a completely different method. Instead of cutting DNA, the system combines a catalytically inactive dCas9 protein with a nucleotide-modifying deaminase enzyme. This way, nucleotides in specific genes are directly converted without creating physical cuts in the genome.
The researchers specifically focused on the start codons of essential genes required for bacterial survival. Normally, AUG start codons, which initiate protein production, are converted into alternative codons, rendering them non-functional. This permanently prevents the bacterium from producing vital proteins. Researchers liken this system to "turning off the power switches" that operate the bacteria's life mechanism.
Another important feature of the system is its "pulse-activated" nature, meaning it is activated in a pulse-like manner. While traditional biosafety systems require the gene editing mechanism to remain continuously active, a short-term activation is sufficient with this new approach. Genetic changes made after a brief induction pulse become permanent, and the bacterium can no longer sustain its life.
Another prominent aspect of the study is the system's ability to target multiple essential genes simultaneously. One of the biggest problems in biocontainment technologies is that, albeit rarely, some bacteria can escape safety mechanisms and continue to survive. These bacteria, defined as "escape mutants," pose a serious risk, especially on an industrial scale. To mitigate this risk, the Seoul National University team simultaneously targeted multiple essential genes with independent biological functions. It is stated that by simultaneously editing vital genes such as holA, ftsB, and dfp, the frequency of escape has been reduced to extremely low levels.
Can Also Make Live Bacterial Therapies Safer
The research team states that the system successfully works not only in standard laboratory bacteria but also in different E. coli strains used for industrial and probiotic purposes. This is considered important for adapting the technology to real-world applications.
The potential uses of this technology are not limited to industrial production. In recent years, live bacterial therapies are also becoming increasingly common. These bacteria, designed to act as drug carriers or therapeutic agents in the human body, are considered among the medical technologies of the future. However, since the uncontrolled proliferation of these bacteria could pose significant safety risks, irreversible biosafety mechanisms like the one developed by Seoul National University are thought to play a critical role in clinical use.
0 Comments: